These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 9808150)

  • 1. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
    Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
    J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.
    Johnson MR; Valentine C; Basilico C; Mansukhani A
    Oncogene; 1998 May; 16(20):2647-56. PubMed ID: 9632141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.
    Wang H; Rubin M; Fenig E; DeBlasio A; Mendelsohn J; Yahalom J; Wieder R
    Cancer Res; 1997 May; 57(9):1750-7. PubMed ID: 9135019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells.
    Fenig E; Wieder R; Paglin S; Wang H; Persaud R; Haimovitz-Friedman A; Fuks Z; Yahalom J
    Clin Cancer Res; 1997 Jan; 3(1):135-42. PubMed ID: 9815549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.
    Wang Q; Maloof P; Wang H; Fenig E; Stein D; Nichols G; Denny TN; Yahalom J; Wieder R
    Exp Cell Res; 1998 Jan; 238(1):177-87. PubMed ID: 9457070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
    Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
    Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathway.
    Fenig E; Szyper-Kravitz M; Yerushalmi R; Lahav M; Beery E; Wasserman L; Gutman H; Nordenberg J
    Oncol Rep; 2002; 9(4):875-7. PubMed ID: 12066225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA; Mehmi I; Lupu R
    Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear accumulation of fibroblast growth factor receptors in human glial cells--association with cell proliferation.
    Stachowiak EK; Maher PA; Tucholski J; Mordechai E; Joy A; Moffett J; Coons S; Stachowiak MK
    Oncogene; 1997 May; 14(18):2201-11. PubMed ID: 9174056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
    Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
    Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM; Brokken LJ; Härkönen PL
    Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
    Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
    J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
    Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
    Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.